These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 3432203)

  • 21. Unithiol in Wilson's disease.
    Walshe JM
    Br Med J (Clin Res Ed); 1985 Mar; 290(6469):673-4. PubMed ID: 3918711
    [No Abstract]   [Full Text] [Related]  

  • 22. [Control of trace elements in the rat using the heavy metal antidote "Unithiol" (sodium-2,3- dimercaptopropane sulfonate)].
    Golbs S; Fuchs V; Pfüller U; Ebert E; Pfeifer D
    Arch Exp Veterinarmed; 1980; 34(3):373-81. PubMed ID: 7436672
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interactions of the chelating agent 2,3-dimercaptopropane-1-sulfonate with red blood cells in vitro. I. Evidence for carrier mediated transport.
    Wildenauer DB; Reuther H; Weger N
    Chem Biol Interact; 1982 Nov; 42(2):165-77. PubMed ID: 7151227
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of mitochondria-derived reactive oxygen species production by the chemilumigenic probes lucigenin and luminol.
    Li Y; Zhu H; Trush MA
    Biochim Biophys Acta; 1999 Jun; 1428(1):1-12. PubMed ID: 10366754
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of Cu/Zn-superoxide dismutase in xenobiotic activation. II. Biological effects resulting from the Cu/Zn-superoxide dismutase-accelerated oxidation of the benzene metabolite 1,4-hydroquinone.
    Li Y; Kuppusamy P; Zweir JL; Trush MA
    Mol Pharmacol; 1996 Mar; 49(3):412-21. PubMed ID: 8643080
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inorganic mercury exposure, mercury-copper interaction, and DMPS treatment in rats.
    Blanusa M; Prester L; Radić S; Kargacin B
    Environ Health Perspect; 1994 Sep; 102 Suppl 3(Suppl 3):305-7. PubMed ID: 7843122
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chelation of lead with DMPS and BAL in rats injected with lead.
    Twarog TA; Cherian MG
    Bull Environ Contam Toxicol; 1983 Feb; 30(2):165-9. PubMed ID: 6839041
    [No Abstract]   [Full Text] [Related]  

  • 28. A simple and effective method for hemolysis with a hypoxanthine-xanthine oxidase system and alteration of erythrocyte phospholipid composition during the hemolysis.
    Taniguchi M; Aikawa M; Sakagami T
    J Biochem; 1981 Mar; 89(3):795-800. PubMed ID: 6895220
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Arsenic and copper excretion after treatment of arsenic poisoning in rats with heavy-metal antagonists.
    Maehashi H; Yamaguchi Y; Tsutsumi S
    Dev Toxicol Environ Sci; 1983; 11():325-8. PubMed ID: 6329629
    [No Abstract]   [Full Text] [Related]  

  • 30. DNA damage caused by reactive oxygen species originating from a copper-dependent oxidation of the 2-hydroxy catechol of estradiol.
    Li Y; Trush MA; Yager JD
    Carcinogenesis; 1994 Jul; 15(7):1421-7. PubMed ID: 8033320
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anticopper efficacy of captopril and sodium dimercaptosulphonate in patients with Wilson's disease.
    Wang XP; Yang RM; Ren MS; Sun BM
    Funct Neurol; 2003; 18(3):149-53. PubMed ID: 14703896
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Luminol-induced neutrophil chemiluminescence.
    Allred CD; Margetts J; Hill HR
    Biochim Biophys Acta; 1980 Aug; 631(2):380-5. PubMed ID: 7407252
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Copper, zinc, and selenium in human blood and urine after injection of sodium 2,3-dimercaptopropane-1-sulfonate: a study on subjects with dental amalgam.
    Høl PJ; Vamnes JS; Gjerdet NR; Eide R; Isrenn R
    Biol Trace Elem Res; 2003 Jan; 91(1):19-31. PubMed ID: 12713026
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Haemolysis during sodium dimercaptosulphonate therapy for Wilson's disease in G6PD-deficient patients: First report of two cases.
    Lai S; Huang YQ; Liu AQ; Wu HW
    J Clin Pharm Ther; 2017 Dec; 42(6):783-785. PubMed ID: 28635014
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Are we ready to replace dimercaprol (BAL) as an arsenic antidote?
    Mückter H; Liebl B; Reichl FX; Hunder G; Walther U; Fichtl B
    Hum Exp Toxicol; 1997 Aug; 16(8):460-5. PubMed ID: 9292286
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Copper(II)-catalyzed lipid peroxidation in liposomes and erythrocyte membranes.
    Chan PC; Peller OG; Kesner L
    Lipids; 1982 May; 17(5):331-7. PubMed ID: 7098774
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reperfusion damage: free radicals mediate delayed membrane changes rather than early ventricular arrhythmias.
    Coetzee WA; Owen P; Dennis SC; Saman S; Opie LH
    Cardiovasc Res; 1990 Feb; 24(2):156-64. PubMed ID: 2328520
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Estimation of mercury burdens in rats by chelation with dimercaptopropane sulfonate.
    Cherian MG; Miles EF; Clarkson TW; Cox C
    J Pharmacol Exp Ther; 1988 May; 245(2):479-84. PubMed ID: 3367303
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chelation of lead by dimercaptopropane sulfonate and a possible diagnostic use.
    Twarog T; Cherian MG
    Toxicol Appl Pharmacol; 1984 Mar; 72(3):550-6. PubMed ID: 6710504
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of cupric ions on the permeability of erythrocyte membrane to non-electrolyte spin labels.
    Gwozdzinski K
    Physiol Chem Phys Med NMR; 1985; 17(4):431-4. PubMed ID: 3014577
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.